Xtant Medical Holdings, Inc. (XTNT) stock
XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 9/3075% below fair value
$0.28−0.00 (-0.94%)
Close on Nov 12, 2026Market cap $38.62MP/E –Yield –
Xtant Medical operating margin
Operating margin is operating income as a percentage of revenue.
Xtant Medical's operating margin for the twelve months ending Jun 30, 2026 was -9.6%. For fiscal 2025 it was 5.4%, against -10.3% the year before. The highest annual figure on record is 5.4% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5.4% | +15.7 |
| FY2024 | Dec 31, 2024 | -10.3% | +0.8 |
| FY2023 | Dec 31, 2023 | -11.1% | +0.5 |
| FY2022 | Dec 31, 2022 | -11.7% | −4.7 |
| FY2021 | Dec 31, 2021 | -7.0% | −5.6 |
| FY2020 | Dec 31, 2020 | -1.4% | +2.1 |
| FY2019 | Dec 31, 2019 | -3.5% | +79.7 |
| FY2018 | Dec 31, 2018 | -83.2% | −37.4 |
| FY2017 | Dec 31, 2017 | -45.8% | −37.4 |
| FY2016 | Dec 31, 2016 | -8.4% | +12.0 |
| FY2015 | Dec 31, 2015 | -20.4% | −2.6 |
| FY2014 | Dec 31, 2014 | -17.7% | +9.5 |
| FY2013 | Dec 31, 2013 | -27.2% | −12.2 |
| FY2012 | Dec 31, 2012 | -15.0% | +6.4 |
| FY2011 | Dec 31, 2011 | -21.4% | +34.5 |
| FY2010 | Dec 31, 2010 | -55.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -39.8% | −52.9 |
| Q1 FY2026 | Mar 31, 2026 | -14.0% | −17.2 |
| Q4 FY2025 | Dec 31, 2025 | -2.9% | +3.1 |
| Q3 FY2025 | Sep 30, 2025 | 7.6% | +21.2 |
| Q2 FY2025 | Jun 30, 2025 | 13.1% | +22.9 |
| Q1 FY2025 | Mar 31, 2025 | 3.2% | +15.7 |
| Q4 FY2024 | Dec 31, 2024 | -6.0% | +7.6 |
| Q3 FY2024 | Sep 30, 2024 | -13.5% | +0.0 |
| Q2 FY2024 | Jun 30, 2024 | -9.8% | −3.0 |
| Q1 FY2024 | Mar 31, 2024 | -12.4% | −3.7 |
| Q4 FY2023 | Dec 31, 2023 | -13.5% | −2.3 |
| Q3 FY2023 | Sep 30, 2023 | -13.5% | −0.4 |
| Q2 FY2023 | Jun 30, 2023 | -6.9% | +1.6 |
| Q1 FY2023 | Mar 31, 2023 | -8.8% | +5.3 |
| Q4 FY2022 | Dec 31, 2022 | -11.3% | +2.4 |
| Q3 FY2022 | Sep 30, 2022 | -13.1% | −2.6 |
| Q2 FY2022 | Jun 30, 2022 | -8.5% | −5.2 |
| Q1 FY2022 | Mar 31, 2022 | -14.1% | −14.1 |
| Q4 FY2021 | Dec 31, 2021 | -13.7% | −15.4 |
| Q3 FY2021 | Sep 30, 2021 | -10.5% | −15.9 |
| Q2 FY2021 | Jun 30, 2021 | -3.3% | +0.4 |
| Q1 FY2021 | Mar 31, 2021 | -0.0% | +9.2 |
| Q4 FY2020 | Dec 31, 2020 | 1.7% | +3.6 |
| Q3 FY2020 | Sep 30, 2020 | 5.4% | +9.9 |
| Q2 FY2020 | Jun 30, 2020 | -3.7% | +0.0 |
| Q1 FY2020 | Mar 31, 2020 | -9.2% | −5.2 |
| Q4 FY2019 | Dec 31, 2019 | -1.9% | +297.8 |
| Q3 FY2019 | Sep 30, 2019 | -4.5% | +3.8 |
| Q2 FY2019 | Jun 30, 2019 | -3.7% | +8.4 |
| Q1 FY2019 | Mar 31, 2019 | -4.0% | +5.2 |
| Q4 FY2018 | Dec 31, 2018 | -299.7% | −174.3 |
| Q3 FY2018 | Sep 30, 2018 | -8.3% | +15.4 |
| Q2 FY2018 | Jun 30, 2018 | -12.1% | +17.6 |
| Q1 FY2018 | Mar 31, 2018 | -9.2% | +2.4 |
| Q4 FY2017 | Dec 31, 2017 | -125.4% | −120.7 |
| Q3 FY2017 | Sep 30, 2017 | -23.7% | −15.4 |
| Q2 FY2017 | Jun 30, 2017 | -29.7% | – |
| Q1 FY2017 | Mar 31, 2017 | -11.6% | – |
| Q4 FY2016 | Dec 31, 2016 | -4.7% | – |
| Q3 FY2016 | Sep 30, 2016 | -8.2% | – |
See a number that looks wrong?